Intelligent Detection of Carotid Plaque and Its Stability Based on Deep Learning Dynamic Ultrasound Scanning

NCT ID: NCT05230576

Last Updated: 2023-09-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-05-01

Study Completion Date

2023-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study intends to build a model through deep learning that can automatically and accurately detect plaques, calculate the lumen stenosis rate and evaluate the stability of plaques based on the carotid transverse axis dynamic ultrasound images and contrast-enhanced ultrasound images, so as to comprehensively evaluate the possibility of carotid plaques. cardiovascular risk. The successful development of this study will automatically simulate and reproduce the whole process of carotid plaque assessment by clinical sonographers. Solve the problem of ultrasonic inspection equipment and experience dependence. It is expected to carry out large-scale population intelligent screening, providing new ideas for early prevention and treatment. Especially in medically underdeveloped remote areas and the lack of experienced sonographers, it has great practical value in clinical health care and can bring greater social and economic benefits.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background:

Carotid plaque is harmful to human health. According to estimates by the World Health Organization, 6.7 million cerebrovascular accidents and strokes occur each year, mainly related to the formation of carotid atherosclerotic plaques. On the one hand, carotid artery plaque can cause carotid artery stenosis or even occlusion, causing cerebral ischemia. Early detection and accurate assessment of carotid plaques are helpful for clinicians to take effective intervention measures, which can significantly reduce the disability rate and fatality rate of stroke.

Carotid CTA and MRA can provide relatively high-resolution and high-quality plaque images, but have cost and scanning limitations that limit their application in daily clinical practice. Ultrasonography has the advantages of non-invasiveness, convenience, low cost, and good repeatability. It is the preferred imaging method for plaque detection, stenosis and plaque stability. Contrast-enhanced ultrasonography (CEUS) can sensitively demonstrate intra-plaque microcirculation perfusion by injecting microbubble contrast agents, and is consistent with histopathological findings, and has been increasingly used clinically to evaluate plaque stability.

However, on the one hand, the limitation of ultrasound examination is that it needs to rely on the level of instruments and operators to improve the accuracy. On the other hand, with the growth of the population base and the aging of society, the traditional medical model has been unable to meet the annual increase in the number of patients. examination needs of patients. Therefore, it is of great significance to develop an integrated AI application platform that can automatically and accurately detect plaque based on ultrasound image data, and evaluate lumen stenosis and plaque stability.

Purpose:

This study intends to build a model based on deep learning to automatically and accurately detect plaque based on the carotid transverse axis dynamic ultrasound image, calculate the lumen stenosis rate, and perform stability assessment, so as to comprehensively evaluate the possible cardiovascular effects of carotid plaque. risk. It will realize the automatic simulation and reproduction of the whole process of assessment of cervical plaque by clinical ultrasound experts.

Study design:

Two-thirds of the enrolled patients and their corresponding carotid artery dynamic scan images and expert diagnosis results were randomly selected as the deep learning training cohort. The carotid artery dynamic scan images and expert diagnosis results of the remaining 1/3 patients were used as a validation cohort to evaluate the overall diagnostic accuracy of the deep learning model

Statistical Analysis:

The sensitivity, specificity, positive predictive value, and negative predictive value of deep learning for detecting plaque, estimating luminal stenosis rate, or predicting plaque stability were calculated by the area under the receiver operating characteristic (ROC) curve (AUROC) to evaluate. Statistical analysis was performed using SPSS 22.0 software.

Quality Control:

Develop standardized and standard carotid ultrasound examination methods and operating procedures, and develop unified image acquisition and storage standards. All operators are rigorously trained in carotid ultrasonography. Two operators with more than 5 years of experience in ultrasound operation were hired as quality control personnel to review all images and exclude unqualified images.

Ultrasound is safe and radiation-free. During the examination, the doctor and the patient were always in a state of communication, and the patient felt less nervous and fearful, with good tolerance and high compliance.

Ethics of the study:

This research will follow the ethical guidelines of the Declaration of Helsinki of the World Medical Congress and the relevant norms and regulations of clinical research. The study will begin after the approval of the ethics committee. Before the start of the study, the investigator should inform the subjects of all relevant contents of the clinical study in easy-to-understand language, and inform the patients that they have the right to withdraw from the study at any time. The study was started only after the patients signed the informed consent voluntarily.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carotid Atherosclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Deep learning training cohort

2/3 of the enrolled patients and their corresponding carotid artery dynamic scan images and expert diagnosis results were randomly selected as the training cohort for deep learning.

Deep learning training cohort

Intervention Type DIAGNOSTIC_TEST

train the deep learning model

Deep learning validation cohort

The carotid artery dynamic scan images and expert diagnosis results of the remaining 1/3 patients were used as a validation cohort to evaluate the overall diagnostic accuracy of the deep learning model.

Deep learning validation cohort

Intervention Type DIAGNOSTIC_TEST

evaluate the model

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Deep learning training cohort

train the deep learning model

Intervention Type DIAGNOSTIC_TEST

Deep learning validation cohort

evaluate the model

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* (1) Age≥18 years old, gender is not limited. (2) Patients who voluntarily participated in this study signed the informed consent.

Exclusion Criteria

* (1) Severe cerebrovascular disease, uncooperative patients, and those who cannot tolerate examination. (2) Wound dressings after neck surgery affects carotid artery ultrasonography. (3) The neck is short and thick, and the probe cannot be put down vertically.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jia Liu

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jia Liu

Attending Physician, Department of Ultrasound, The Third Affiliated Hospital of Sun Yat-sen University

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jia Liu

Role: PRINCIPAL_INVESTIGATOR

Third Affiliated Hospital, Sun Yat-Sen University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Third Affiliated Hospital of Sun Yat-sen University

Guangzhou, Guangdong, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Abbott AL, Paraskevas KI, Kakkos SK, Golledge J, Eckstein HH, Diaz-Sandoval LJ, Cao L, Fu Q, Wijeratne T, Leung TW, Montero-Baker M, Lee BC, Pircher S, Bosch M, Dennekamp M, Ringleb P. Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis. Stroke. 2015 Nov;46(11):3288-301. doi: 10.1161/STROKEAHA.115.003390. Epub 2015 Oct 8.

Reference Type BACKGROUND
PMID: 26451020 (View on PubMed)

Nighoghossian N, Derex L, Douek P. The vulnerable carotid artery plaque: current imaging methods and new perspectives. Stroke. 2005 Dec;36(12):2764-72. doi: 10.1161/01.STR.0000190895.51934.43. Epub 2005 Nov 10.

Reference Type BACKGROUND
PMID: 16282537 (View on PubMed)

Saba L, Saam T, Jager HR, Yuan C, Hatsukami TS, Saloner D, Wasserman BA, Bonati LH, Wintermark M. Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications. Lancet Neurol. 2019 Jun;18(6):559-572. doi: 10.1016/S1474-4422(19)30035-3. Epub 2019 Apr 4.

Reference Type BACKGROUND
PMID: 30954372 (View on PubMed)

Rafailidis V, Charitanti A, Tegos T, Destanis E, Chryssogonidis I. Contrast-enhanced ultrasound of the carotid system: a review of the current literature. J Ultrasound. 2017 Feb 9;20(2):97-109. doi: 10.1007/s40477-017-0239-4. eCollection 2017 Jun.

Reference Type BACKGROUND
PMID: 28592999 (View on PubMed)

Deyama J, Nakamura T, Takishima I, Fujioka D, Kawabata K, Obata JE, Watanabe K, Watanabe Y, Saito Y, Mishina H, Kugiyama K. Contrast-enhanced ultrasound imaging of carotid plaque neovascularization is useful for identifying high-risk patients with coronary artery disease. Circ J. 2013;77(6):1499-507. doi: 10.1253/circj.cj-12-1529. Epub 2013 Mar 22.

Reference Type BACKGROUND
PMID: 23519900 (View on PubMed)

Varetto G, Gibello L, Castagno C, Quaglino S, Ripepi M, Benintende E, Gattuso A, Garneri P, Zan S, Capaldi G, Bertoldo U, Rispoli P. Use of Contrast-Enhanced Ultrasound in Carotid Atherosclerotic Disease: Limits and Perspectives. Biomed Res Int. 2015;2015:293163. doi: 10.1155/2015/293163. Epub 2015 Jun 21.

Reference Type BACKGROUND
PMID: 26180793 (View on PubMed)

Staub D, Patel MB, Tibrewala A, Ludden D, Johnson M, Espinosa P, Coll B, Jaeger KA, Feinstein SB. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke. 2010 Jan;41(1):41-7. doi: 10.1161/STROKEAHA.109.560342. Epub 2009 Nov 12.

Reference Type BACKGROUND
PMID: 19910551 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

[2020]02-255-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.